Home Induced testosterone deficiency: from clinical presentation of fatigue, erectile dysfunction and muscle atrophy to insulin resistance and diabetes
Article
Licensed
Unlicensed Requires Authentication

Induced testosterone deficiency: from clinical presentation of fatigue, erectile dysfunction and muscle atrophy to insulin resistance and diabetes

  • George Yu and Abdulmaged M. Traish EMAIL logo
Published/Copyright: October 1, 2011

Abstract

Over the past 60 years, androgen deprivation therapy has been the mainstay of treatment of metastatic prostate cancer. However, research findings suggest that androgen deprivation therapy inflicts serious adverse effects on overall health and reduces the quality of life. Among the adverse effects known to date are insulin resistance, diabetes, metabolic syndrome fatigue, erectile dysfunction, and cardiovascular disease. In this clinical perspective, we discuss the relationship between induced androgen deficiency and a host of pathologies in the course of treatment with androgen deprivation therapy for prostate cancer patients.


Corresponding author: Abdulmaged M. Traish, MBA, PhD, Professor of Biochemistry, Professor of Urology, Boston University School of Medicine, 715 Albany Street, A502, Boston, MA 02118, USA Phone: +1-617-638-4578, Fax: +1-617-638-5412

Received: 2011-10-11
Accepted: 2011-11-18
Published Online: 2011-10-01
Published in Print: 2011-10-01

©2011 by Walter de Gruyter Berlin Boston

Downloaded on 4.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/HMBCI.2011.131/html
Scroll to top button